Ipsen SA ADR IPSEY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $40.65
- Day Range
- $40.00–40.00
- 52-Week Range
- $32.68–51.10
- Bid/Ask
- $25.28 / $66.16
- Shares Outstanding
- 329.67M
- Market Cap
- $13.18B
- Volume/Avg
- 1,126 / 1,051
Key Statistics
- Price/Earnings (Normalized)
- 11.26
- Price/Sales
- 2.70
- Dividend Yield (Trailing)
- 1.14%
- Dividend Yield (Forward)
- 1.14%
- Dividend Payment Schedule
- Jun
- Total Yield
- 1.80%
Company Profile
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 5,535
- Website
- https://www.ipsen.com
Competitors
Valuation
|
Metric
|
IPSEY
|
JAZZ
|
UCB
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.26 | 8.62 | 16.55 |
Price/Book Value | 2.50 | 2.84 | 3.23 |
Price/Sales | 2.70 | 2.94 | 4.50 |
Price/Cash Flow | 8.80 | 7.92 | 15.78 |
Price/Earnings
IPSEY
JAZZ
UCB
Financial Strength
|
Metric
|
IPSEY
|
JAZZ
|
UCB
|
|---|---|---|---|
Quick Ratio | 1.76 | 1.38 | 0.82 |
Current Ratio | 1.97 | 1.78 | 1.20 |
Interest Coverage | 15.24 | 5.26 | 27.73 |
Quick Ratio
IPSEY
JAZZ
UCB
Profitability
|
Metric
|
IPSEY
|
JAZZ
|
UCB
|
|---|---|---|---|
Return on Assets (Normalized) | 15.69% | 16.01% | 13.57% |
Return on Equity (Normalized) | 25.09% | 42.74% | 23.59% |
Return on Invested Capital (Normalized) | 21.65% | 20.79% | 19.03% |
Return on Assets
IPSEY
JAZZ
UCB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|fpXC&TLt | LOCK|Jl$K | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|D!$g#@KR | LOCK|h^tml | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|bhS!rw | LOCK|Vz | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|&WQh%?M | LOCK|Z@ | $31B | |||
| Viatris Inc
VTRS
| LOCK|<?>D$y? | LOCK|G# | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|j@J | LOCK|!q | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|b>fy%xS | LOCK|@dG | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|Vln^<$% | LOCK|?B | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|#@>RV% | LOCK|L@%Cw | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|jyJ?>^ | LOCK|<@y | $2B |
United States